HM Payson & Co’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $35.9K | Sell |
525
-275
| -34% | -$18.8K | ﹤0.01% | 696 |
|
|
2024
Q4 | $62.2K | Sell |
800
-330
| -29% | -$25.7K | ﹤0.01% | 608 |
|
|
2024
Q3 | $75.8K | Sell |
1,130
-278
| -20% | -$18.6K | ﹤0.01% | 569 |
|
|
2024
Q2 | $160K | Sell |
1,408
-372
| -21% | -$42.2K | ﹤0.01% | 435 |
|
|
2024
Q1 | $247K | Buy |
1,780
+100
| +6% | +$13.9K | ﹤0.01% | 364 |
|
|
2023
Q4 | $208K | Buy |
1,680
+200
| +14% | +$24.8K | ﹤0.01% | 376 |
|
|
2023
Q3 | $138K | Buy |
1,480
+116
| +9% | +$10.8K | ﹤0.01% | 435 |
|
|
2023
Q2 | $175K | Buy |
1,364
+200
| +17% | +$25.7K | ﹤0.01% | 389 |
|
|
2023
Q1 | $135K | Hold |
1,164
| – | – | ﹤0.01% | 426 |
|
|
2022
Q4 | $132K | Buy |
1,164
+24
| +2% | +$2.72K | ﹤0.01% | 427 |
|
|
2022
Q3 | $92K | Hold |
1,140
| – | – | ﹤0.01% | 480 |
|
|
2022
Q2 | $85K | Hold |
1,140
| – | – | ﹤0.01% | 492 |
|
|
2022
Q1 | $146K | Buy |
1,140
+60
| +6% | +$7.68K | ﹤0.01% | 437 |
|
|
2021
Q4 | $145K | Sell |
1,080
-120
| -10% | -$16.1K | ﹤0.01% | 441 |
|
|
2021
Q3 | $164K | Hold |
1,200
| – | – | ﹤0.01% | 416 |
|
|
2021
Q2 | $128K | Hold |
1,200
| – | – | ﹤0.01% | 444 |
|
|
2021
Q1 | $108K | Hold |
1,200
| – | – | ﹤0.01% | 471 |
|
|
2020
Q4 | $111K | Sell |
1,200
-1,008
| -46% | -$93.2K | ﹤0.01% | 459 |
|
|
2020
Q3 | $228K | Buy |
2,208
+1,008
| +84% | +$104K | 0.01% | 340 |
|
|
2020
Q2 | $122K | Hold |
1,200
| – | – | ﹤0.01% | 412 |
|
|
2020
Q1 | $81K | Buy |
+1,200
| New | +$81K | ﹤0.01% | 425 |
|